Jason S. Lewis

Director

Share
Print
Share
Print
Pictured: Jason Lewis

Office Phone

646-888-3038

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Jason S. Lewis discloses the following relationships and financial interests:

  • CSRA Inc.
    Provision of Services
  • CheMatech
    Intellectual Property Rights
  • Clarity Pharmaceuticals
    Provision of Services
  • Elsevier
    Provision of Services
  • Elucida Oncology
    Intellectual Property Rights
  • Evergreen Theragnostics
    Ownership / Equity Interests; Provision of Services (uncompensated)
  • Invicro, LLC
    Provision of Services
  • Journal of Nuclear Medicine
    Provision of Services
  • Samus Therapeutics LLC
    Intellectual Property Rights
  • Summit Biomedical Imaging, LLC
    Ownership / Equity Interests
  • TPG Capital
    Provision of Services
  • Telix Pharmaceuticals Limited
    Ownership / Equity Interests; Provision of Services (uncompensated)
  • Theragnostics, Ltd.
    Intellectual Property Rights
  • Trace-Ability
    Ownership / Equity Interests; Provision of Services (uncompensated)
  • World Molecular Imaging Society
    Provision of Services
  • pHLIP, Inc.
    Intellectual Property Rights; Ownership / Equity Interests; Provision of Services

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures